Status and phase
Conditions
Treatments
About
Efficacy and tolerability of ABB i5 prebiotic and ABB C22 postbiotics for the management of constipation and gastrointestinal well-being: a pilot trial
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Inpatients of the centre
Exclusion criteria
History of allergy, idiosyncrasy, hypersensitivity or adverse reactions to the active principle or to any of the excipients.
Primary purpose
Allocation
Interventional model
Masking
100 participants in 4 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal